Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with advanced prostate cancer.
LAMPGEN ANALYSIS
Why it matters
Introduced oral gonadotropin-releasing hormone receptor antagonism as an androgen deprivation option.
What research teams should watch
Make daily adherence and interacting medicines part of follow-up and track testosterone suppression.
PRIMARY RECORDS